Thomson Reuters Medical Literature Analyzer delivers value across key businesses.

Medical affairs and publications planning

• Access critical information on the clinical themes, concepts, and messages that are being disseminated in scientific literature
• Conduct focused and effective publication planning using key strategic and tactical information tools
• Identify prominent authors and investigators working in a therapeutic area
• Ensure manuscripts under development maximize the ROI from your communications budget

Marketing, branding, and positioning

• Identify gaps in your messaging and that of your competitors
• Obtain critical information about how your competitors launched their products
• Monitor scientific literature and key medical meetings to identify new competitors
• Obtain feedback on the strength, diversity, and value of the messages your target audience is receiving about your products

Competitive intelligence

• Enhance your product positioning by receiving key intelligence about your competitors
• Stay alert to competitive threats and obtain the information you need to respond quickly and effectively
• Respond quickly to new messaging strategies from your existing competitors

Business development and licensing

• Identify new opportunities in the market place
• Benefit from more than 60 tabular and graphic reports to guide and support investment, licensing, and other product and business development efforts

Regulatory Affairs and clinical development

• Access critical information that will inform the planning of clinical trials for products in development or pre-launch
• Identify specific competitive product weaknesses and turn them into positives when positioning your product

• View FAQs here.

Who’s Making The Biggest Splash? Our Findings

The international pharmaceutical industry is among the most important sponsors of scientific research, so it is understandable that some of the most widely published authors of scientific articles are affiliated with, or sponsored by, pharmaceutical companies.

In this quarterly update of the scientific literature on drugs and therapies, Thomson Reuters has assessed the quantity and quality of the materials published by pharmaceutical companies, research institutions and other non-commercial bodies in the last three months to identify which organization has made the biggest splash. View our methodology 

The Organizations that have made the biggest impact in the leading sources of information on medical research (October – December 2009)

Comparison of mean Thomson Source Scores for industry and non-commercial bodies (October - December 2009)

Notes:

1. These analyses span more than 30 therapeutic areas covered by Medical Literature Analyzer
2. For the meanings of these terms, see our methodology section
3. Not ranked in the top-tier last quarter
4. Includes individuals, research institutes and other non-commercial organizations